|Title:||Compositions containing fixed combinations|
|Abstract:||Continuous administration of compositions containing a fixed quantity of synthetic estrogen in combination with a synthetic progestogenic agent are useful to relieve menopausal symptoms, to prevent osteoporosis and for other hormone-replacement treatments. Also described is an improved manufacturing process for such compositions especially for low tablet dosage forms.|
|Inventor(s):||Boissonneault; Roger M. (Long Valley, NJ), Miller, Jr.; Henry A. (Lake Hopatcong, NJ)|
|Assignee:||Warner-Lambert Company (Morris Plains, NJ)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Dosage form;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.